Published in Endocrinology on October 01, 1988
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol (1977) 3.17
In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone. Antimicrob Agents Chemother (1996) 2.76
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Growth factors in the extracellular matrix. FASEB J (1997) 2.71
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol (1986) 2.44
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev (1999) 2.22
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol (1994) 2.15
Mechanism of action of phalloidin on the polymerization of muscle actin. Biochemistry (1981) 2.12
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem (1987) 2.05
Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol Biol Cell (2000) 2.01
Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res (1996) 1.91
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A (2001) 1.83
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech (2001) 1.70
Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem (1991) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell (1976) 1.64
Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem (1995) 1.61
Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res (1989) 1.55
Detection of conformational changes in actin by proteolytic digestion: evidence for a new monomeric species. J Mol Biol (1976) 1.55
Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem (1992) 1.50
Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J (1996) 1.50
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J (1998) 1.48
Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res (1998) 1.48
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer (1999) 1.38
Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development (2000) 1.38
Epstein-Barr virus-associated thymidine kinase. J Virol (1978) 1.38
Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics. Biochemistry (1999) 1.37
Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene (2000) 1.37
Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem (2000) 1.36
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J (1989) 1.35
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem (1996) 1.35
Properties of nonheme iron in a cell envelope fraction from Escherichia coli. J Bacteriol (1971) 1.34
Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res (1986) 1.32
Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer (1982) 1.31
Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells. J Cell Physiol (1980) 1.30
Direct association of fibronectin and actin molecules in vitro. J Cell Biol (1980) 1.28
Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J Biol Chem (1998) 1.24
Nucleotide binding to actin. Cation dependence of nucleotide dissociation and exchange rates. J Biol Chem (1993) 1.24
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct (1976) 1.23
Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci (2001) 1.23
Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J (2001) 1.22
Interaction of viral envelope glycoproteins with fibronectin. Infect Immun (1983) 1.21
Transforming growth factor beta regulation of cell proliferation. J Cell Physiol Suppl (1987) 1.18
Distribution of a major surface-associated glycoprotein, fibronectin, in cultures of adherent cells. J Supramol Struct (1977) 1.18
1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ (2000) 1.14
Trigger digits in children. J Hand Surg Br (2001) 1.13
Comparison of rectosigmoid motility in normal children, children with recurrent abdominal pain, and children with ulcerative colitis. Pediatrics (1967) 1.13
Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem (1999) 1.12
Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem (1992) 1.12
The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein. Biochim Biophys Acta (1982) 1.09
Formation of the yeast mitochondrial membrane. 1. Effects of inhibitors of protein synthesis on the kinetics of enzyme appearance during glucose derepression. Eur J Biochem (1973) 1.08
Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol (1994) 1.04
Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones. Exp Cell Res (1987) 1.04
Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin. Biophys J (1998) 1.03
Tight binding of divalent cations to monomeric actin. Binding kinetics support a simplified model. J Biol Chem (1987) 1.02
Actin filament annealing in the presence of ATP and phalloidin. Biochemistry (1993) 1.02
Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities. J Leukoc Biol (1984) 1.02
Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. Am J Obstet Gynecol (1976) 1.02
Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol (2008) 1.02
Interaction of fibronectin with complement component C3. Scand J Immunol (1983) 1.01
Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem (1995) 1.01
Ca2+ regulation of gelsolin activity: binding and severing of F-actin. Biophys J (1998) 1.00
Preparation and polymerization properties of monomeric ADP-actin. Biochim Biophys Acta (1989) 1.00
Extracellular matrix proteins characterize human tumor cell lines. Int J Cancer (1981) 1.00
Disruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings. Biochem Soc Trans (1995) 0.99
Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology (1999) 0.99
Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers. Antimicrob Agents Chemother (2000) 0.98
Bound-cation exchange affects the lag phase in actin polymerization. Biochemistry (1984) 0.97
The tightly bound divalent cation regulates actin polymerization. Biochem Biophys Res Commun (1983) 0.97
Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene (2001) 0.96
Nucleotide exchange and rheometric studies with F-actin prepared from ATP- or ADP-monomeric actin. Biophys J (1993) 0.96
Isolation of an actin-binding fragment of fibronectin. Biochem J (1981) 0.95
High affinity binding of divalent cation to actin monomer is much stronger than previously reported. Biochem Biophys Res Commun (1986) 0.95
The lipid content of amyloid fibrils purified by a variety of methods. Am J Pathol (1967) 0.95
Rapid membrane changes in mouse epithelial cells after exposure to epidermal growth factor. J Ultrastruct Res (1981) 0.94
A proposed mechanism of action of cytochalasin D on muscle actin. Biochem Biophys Res Commun (1980) 0.93
Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol (2005) 0.93
Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem (1998) 0.93
Thermodynamics of actin polymerization; influence of the tightly bound divalent cation and nucleotide. Biochim Biophys Acta (1991) 0.93
Developmental coordination of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and acute hCG responsiveness in cultured and freshly harvested porcine granulosa cells. Endocrinology (1984) 0.93
Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. Science (1981) 0.92
Keratin filaments of mouse epithelial cells are rapidly affected by epidermal growth factor. J Cell Biol (1981) 0.92
Fibronectin and the pericellular matrix of normal and transformed adherent cells. Ann N Y Acad Sci (1978) 0.91
Fibroblast surface antigen (SF): the external glycoprotein lost in proteolytic stimulation and maligant transfromation. Int J Cancer (1976) 0.91
Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol (1983) 0.90
Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology (1987) 0.90
A kinetic comparison between Mg-actin and Ca-actin. J Muscle Res Cell Motil (1986) 0.90
Influence of the high affinity divalent cation on actin tryptophan fluorescence. Adv Exp Med Biol (1994) 0.90
Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Br J Dermatol (1997) 0.90
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res (1995) 0.90
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer (2006) 0.90
Transforming growth factors-beta as regulators of cellular growth and phenotype. Crit Rev Oncog (1992) 0.89
2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod (2001) 0.89